Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sana Biotechnology Inc (NASDAQ: SANA) closed the day trading at $3.76 down -1.31% from the previous closing price of $3.81. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 0.7 million shares were traded. SANA stock price reached its highest trading level at $3.85 during the session, while it also had its lowest trading level at $3.728.
Ratios:
For a better understanding of SANA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 26, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On January 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $12.
On September 25, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $9.JMP Securities initiated its Mkt Outperform rating on September 25, 2023, with a $9 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 21 ’24 when NATHAN HARDY bought 45,796 shares for $3.95 per share.
Mulligan Richard sold 150,000 shares of SANA for $612,570 on Sep 24 ’24. The Director now owns 2,848,121 shares after completing the transaction at $4.08 per share. On Sep 25 ’24, another insider, Mulligan Richard, who serves as the Director of the company, sold 150,000 shares for $3.89 each. As a result, the insider received 583,170 and left with 2,698,121 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 843146112 and an Enterprise Value of 683385920.
Stock Price History:
Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is -18.47%, while the 200-Day Moving Average is calculated to be -43.71%.
Shares Statistics:
Over the past 3-months, SANA traded about 1.37M shares per day on average, while over the past 10 days, SANA traded about 769360 shares per day. A total of 197.86M shares are outstanding, with a floating share count of 121.63M. Insiders hold about 45.33% of the company’s shares, while institutions hold 51.09% stake in the company. Shares short for SANA as of 1728950400 were 33279567 with a Short Ratio of 24.33, compared to 1726185600 on 31169232. Therefore, it implies a Short% of Shares Outstanding of 33279567 and a Short% of Float of 31.04.
